paraquat has been researched along with quinacrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Fabisiak, JP; Kagan, VE; Lazo, JS; Tyurin, VA; Tyurina, YY | 1 |
3 other study(ies) available for paraquat and quinacrine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Paraquat-induced phosphatidylserine oxidation and apoptosis are independent of activation of PLA2.
Topics: Animals; Apoptosis; Enzyme Activation; Enzyme Inhibitors; Interleukin-3; Mice; Oxidation-Reduction; Paraquat; Phosphatidylserines; Phospholipases A; Phospholipases A2; Quinacrine | 1998 |